CHF

Randomized trial suggests benefit is largely in those with 40-60% ejection fraction

TVT registry compares outcomes with Evolut FX and Pro+

Approval study analysis suggests best practices

But procedure no less effective for this higher risk group, COAPT trial post hoc analysis shows

Benefits similar across anatomical complexity, advanced heart failure in post-marketing studies

Future treatments don't have to be limited to slowing disease, case series suggests

SGLT1/SGLT2 inhibitor approved on the basis of SOLOIST-WHF, SCORED trials

Compared with biventricular pacing, increase in LVEF was found to be significant

6-month follow-up with investigational device gives support for pivotal trial

TMVR fares at least as well as conservative treatment in observational analysis

Study underscores importance of anatomical, physiological parameters

SPRINT post hoc analysis suggests a means for prevention

A "scandal" that routine care doesn't include talks about larger life goals, says surgeon-writer

Choose the first procedure wisely, because repeats have mortality implications, researchers say